Focus Partners Wealth Sells 18,538 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Focus Partners Wealth decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 53,036 shares of the medical equipment provider's stock after selling 18,538 shares during the quarter. Focus Partners Wealth's holdings in Intuitive Surgical were worth $27,683,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ISRG. Bennett Selby Investments LP lifted its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC lifted its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares during the last quarter. LVW Advisors LLC boosted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. grew its holdings in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after purchasing an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC lifted its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 1.0%

ISRG stock traded down $5.66 during trading on Thursday, hitting $560.28. The company had a trading volume of 1,793,655 shares, compared to its average volume of 1,637,751. The stock has a market cap of $200.81 billion, a price-to-earnings ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $386.00 and a 12 month high of $616.00. The firm has a 50-day moving average price of $502.26 and a 200-day moving average price of $535.79.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company earned $1.50 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ISRG shares. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Finally, Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 810 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. This represents a 63.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares of the company's stock, valued at $4,060,424.28. This trade represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,680 shares of company stock valued at $16,854,345 in the last 90 days. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.